🇺🇸 FDA
Patent

US 7247316

Compositions and methods for treating lymphoma

granted A61KA61K31/475A61K31/704

Quick answer

US patent 7247316 (Compositions and methods for treating lymphoma) held by The Board of Regents of the University of Texas System expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/475, A61K31/704, A61K9/127, A61K9/1278